Combination Immunotherapy: An Emerging Paradigm in Cancer Therapeutics

被引:0
|
作者
Wang, Daniel Y. [1 ]
Sosman, Jeffrey A. [2 ]
Johnson, Douglas B. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN 37235 USA
[2] Vanderbilt Univ, Med Ctr, Melanoma & Tumor Immunotherapy Program, Nashville, TN 37235 USA
来源
ONCOLOGY-NEW YORK | 2015年 / 29卷 / 12期
关键词
PD-1; BLOCKADE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1005 / 1006
页数:2
相关论文
共 50 条
  • [21] Peptide therapeutics and assemblies for cancer immunotherapy
    Li, Mingming
    Zhao, Xinran
    Dai, Jianfang
    Yu, Zhilin
    SCIENCE CHINA-MATERIALS, 2019, 62 (11) : 1759 - 1781
  • [22] Trimetazidine an emerging paradigm in renal therapeutics: Preclinical and clinical insights
    Gupta, Kirti
    Pandey, Sneha
    Bagang, Newly
    Mehra, Kamalpreet
    Singh, Gaaminepreet
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 913
  • [23] Combination Therapy for Mitral Regurgitation: An Emerging Paradigm
    Rogers, Jason H.
    STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM, 2018, 2 (02): : 155 - 156
  • [24] Combination immunotherapy for cancer
    Fearon, Douglas
    JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 213 (07): : 1115 - 1115
  • [25] Viral Proteins as Emerging Cancer Therapeutics
    Manocha, Ekta
    Caruso, Arnaldo
    Caccuri, Francesca
    CANCERS, 2021, 13 (09)
  • [26] Emerging therapeutics for targeting Akt in cancer
    Gdowski, Andrew
    Panchoo, Marlyn
    Van Treuren, Timothy
    Basu, Alakananda
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 757 - 768
  • [27] Cancer Therapeutics: Emerging Targets and Trends
    Ullah, Mohd. Fahad
    CURRENT CANCER THERAPY REVIEWS, 2008, 4 (01) : 50 - 56
  • [28] Emerging therapeutics for primary peritoneal cancer
    Slomovitz, Brian M.
    Worley, Michael J.
    Markman, Maurie
    Coleman, Robert L.
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (01) : 71 - 84
  • [29] Radiotherapy and immunotherapy combination: paradigm changing or just hype?
    Dovedi, S. J.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S5 - S5
  • [30] Emerging Adjuvants for Cancer Immunotherapy
    Hu, Hong-Guo
    Li, Yan-Mei
    FRONTIERS IN CHEMISTRY, 2020, 8